Teva North America Recall: Capecitabine tablets USP 500 mg, Cytotoxic Agent, Rx Only, 120
Teva North America Recall: Capecitabine tablets USP 500 mg, Cytotoxic Agent, Rx Only, 120 is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Teva North America; Product: Capecitabine tablets USP 500 mg, Cytotoxic Agent, Rx Only, 120 tablets per bottle, Manufactured in Czech Republic by: T
| Recalling firm | Teva North America |
|---|---|
| Product | Capecitabine tablets USP 500 mg, Cytotoxic Agent, Rx Only, 120 tablets per bottle, Manufactured in Czech Republic by: Teva Czech Industries sro, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-7474-89 |
| Reason for recall | Failed Dissolution Specifications: low test results at the 18 month time-point |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide |
| Recall initiated | 20151221 |
| Recall number | D-0732-2016 |
| Category | drug |
| State | PA |
| Country | United States |
$29/mo
Try RecallGuard →